SCHEMBL16257590

SCHEMBL16257590

Cc1c(Nc2ccc(Cl)c(C(F)(F)F)c2)ncnc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KIT P10721 2/20 0.50
DHODH Q02127 2/20 0.48
KDR P35968 4/20 0.48
NTRK1 P04629 1/20 0.48
NTRK3 Q16288 1/20 0.48
NTRK2 Q16620 1/20 0.48
HDAC3 O15379 3/20 0.47
HDAC1 Q13547 3/20 0.47
RAPGEF4 Q8WZA2 1/20 0.47
HDAC6 Q9UBN7 2/20 0.46
RET P07949 1/20 0.46
CSNK2A1 P68400 1/20 0.46
GRM4 Q14833 1/20 0.46
KMO O15229 1/20 0.45
TOP2B Q02880 1/20 0.45
RAF1 P04049 1/20 0.45
BRAF P15056 1/20 0.45
PDK1 Q15118 1/20 0.44
AURKB Q96GD4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12179967 0.86 DHODH (0.52) KITDHODHKDRNTRK1NTRK3
SCHEMBL15033668 0.85 KMO (0.58) KDRHDAC3HDAC1HDAC6GRM4
SCHEMBL10958359 0.83 RAPGEF4 (0.53) KITDHODHKDRNTRK1NTRK3
SCHEMBL14306362 0.79 LMNA (0.58) DHODHKDRCSNK2A1
SCHEMBL16257589 0.74 CSNK2A2 (0.48) DHODHCSNK2A1GRM4
SCHEMBL16257566 0.73 MEN1 (0.42) DHODHCSNK2A1KMO
SCHEMBL16257514 0.72 KDM4E (0.46)
SCHEMBL30683234 0.72 KIT (0.49) KITKDRNTRK1NTRK3NTRK2
SCHEMBL16257609 0.71 CSF1R (0.47) KDR
SCHEMBL2329430 0.71 KDR (0.78) KDRHDAC1HDAC6GRM4PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946218-B2 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-02-03 US disclosed
EP-2569295-B1 NEW CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed